ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NSCI Netscientific Plc

53.50
0.00 (0.00%)
18 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 53.50 53.00 54.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1.45M -2.64M -0.1104 -4.85 12.81M
Netscientific Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NSCI. The last closing price for Netscientific was 53.50p. Over the last year, Netscientific shares have traded in a share price range of 53.50p to 77.00p.

Netscientific currently has 23,945,828 shares in issue. The market capitalisation of Netscientific is £12.81 million. Netscientific has a price to earnings ratio (PE ratio) of -4.85.

Netscientific Share Discussion Threads

Showing 5901 to 5919 of 6000 messages
Chat Pages: 240  239  238  237  236  235  234  233  232  231  230  229  Older
DateSubjectAuthorDiscuss
04/7/2024
17:09
From yesterday.

Another of Martlet's portfolio so good news for us.

Rovco is pleased to announce the successful completion of a £30.6 million investment round, which brings a major offshore wind operator into the business alongside our current shareholders.

This substantial funding will fuel international expansion, building on recent contract wins in the US, Mainland Europe, and Asian markets. The investment will be used to bolster our in-house autonomy and AI software teams, accelerating the deployment of cutting-edge technologies that are set to revolutionise the offshore wind industry.

Brian Allen, CEO of Rovco, commented, "This is a thrilling chapter in Rovco's journey. Over the next 3-6 months, we anticipate making several groundbreaking announcements that will redefine our industry. This latest fundraising round is expected to be our penultimate step before taking the company public in a few years. Our sustained growth underscores the dedication of our incredibly talented teams and the unwavering support of our customers, as we continue to drive innovation and set new standards in the offshore wind sector with autonomous and AI technologies.”

loafofbread
26/6/2024
20:47
They had the chance to grasp the buy back nettle at the IM but made excuses.

Can't see much better investments than buying stock at 70p when it's worth more than £2.00 and increasing each month.

At some point they will get a cash infusion from ProAxis sale/Glycotest deal/PDSB TO/plastics deal, etc.

They have approx 90 investments already running so I have little interest in using that cash at seed level for a return in 5/10 years.

Perhaps they want the share price kept low to take it private like the rest of AIM?

loafofbread
26/6/2024
17:17
NSCI is always lightly traded, so there cannot be many followers or new investors. I think that there is a lack of promotion to the right audience.

Despite MM has marked down the price by 1p today the spread has narrowed from 6p to only 1 p (72-73p). It would appear that MM wants sellers to sell them the stock, as they keep a tight book. In this respect, any pent up demand generated by, for example, an investment recommendation by IC or others, will raise the share price by a few pence.

Anyway, as I have iterated before, unless and until the company has realised real cash in exiting one or more of its investments the share price will reach 90 p - 100 p at best in the next few months. If achieved, that is not a bad return.

Years ago, I realised that investment trusts were mostly trading at a discount to their underlying assets whilst Unit Trusts were trading at a premium. This is a perception issue. NSCI is acting like an investment trust, investing in a number of companies that may generate a good return.

I have no doubt in my mind that one day, we only need a blockbuster to increase the value of NSCI many folds. We live in hope.

kingston78
26/6/2024
14:20
PDSB up almost 5% early doors
blakieboy7
26/6/2024
09:08
Referring to my post 5896, POLX is on the move. The train is leaving the station.
kingston78
25/6/2024
15:20
PDSB up over 19% so far
blakieboy7
25/6/2024
13:34
It may not be appropriate for me to suggest other shares on this thread, but I would like my fellow investors to make money. I am convinced that Genedrive (GDR) and Polarean (POLX) are both about to take off. You can double your money in both of them in quick order.

PLEASE DYOR. Good luck.

kingston78
25/6/2024
11:32
It is strange that MM has marked down the price by 3.5 p but narrowing down the spread to 2 p.
kingston78
25/6/2024
09:15
If Merck were to bid for PDSB at its lowest point in terms of share price (it was US$14 now less than US$3), with a likely chance of success medically, it would be a great gamble for Merck. This is the cheapest route to the drug being developed by PDSB.

NSCI will therefore crystallise its investment in PDSB, hopefully at least breakeven, but get some cash in its coffer.

kingston78
24/6/2024
19:13
The spread is 5 p from 74-79 (mid 76.5). There is scope for narrowing this down if there is demand. MM wants your shares so that they can sell to others. A big spread will actually discourage sellers. Accordingly, I think that the share price will move up by 2p to 76-80.
kingston78
24/6/2024
12:57
I have tripled my investment in CAP-XX in a short space of time, and have done well despite pull back at POLX.

NSCI is one of my longest and largest shareholdings. It is a hard nut to crack. It seems to be heading in the right direction now.

kingston78
24/6/2024
09:39
Like a blue monday!
blakieboy7
22/6/2024
08:30
On a one-year chart NSCI is at the top of its trading band. On a two-year chart it would go up to 90 p. Over a three year/five year chart we would see 120 p more than once, and 150 p to 180 p as a brief event.

I would therefore surmise that unless the company actually has turned some of its investments into real cash, not paper profit / value the best that we can hope for in the next few months is 90 to 100 p (still under value).

Perception is an illusion, but it is more powerful than reality. Or maybe you can turn it on its head to say that "reality is an illusion and it is more powerful than perception".

Ultimately cash is king.

kingston78
22/6/2024
08:17
Oak bloke has done a decent write up on the Martlet portfolio (Part 1)

Yet again shows the crazy value gap.

loafofbread
21/6/2024
17:43
Not a bad week.
loafofbread
20/6/2024
08:32
Please refer my posting 5882 on Polarean (POLX). It is going to take off.
kingston78
20/6/2024
08:16
The spread was 4 p (71-75) at the close yesterday. It was bound to go up today by at least 1 p if MM were to narrow the spread. Anyway, it has maintained a 4 p spread, but up by 1p (72-76). There is further to go until large demand pushes up the price to £1 in the next two months. There has been regular positive news update in incremental underlying value of the company's portfolio. I hope that it will not be too long before a cash exit from one of its investments.
kingston78
20/6/2024
07:44
Creeping up
blakieboy7
19/6/2024
08:15
I also have a massive holding in Genedrive (GDR) which has a recent placing at 1.5 p.

It is expecting to receive excellent news from NICE by mid-July. Its price was stagnant but it is about to move upwards soon. My target 5 p.

kingston78
Chat Pages: 240  239  238  237  236  235  234  233  232  231  230  229  Older